[Federal Register Volume 77, Number 152 (Tuesday, August 7, 2012)]
[Notices]
[Pages 47106-47108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-19191]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; SA 
INTL GMBH C/O., Sigma Aldrich Co. LLC

    Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this 
is notice that on May 2, 2012, SA INTL GMBH C/O., Sigma Aldrich Co. 
LLC., 3500 Dekalb Street, St. Louis, Missouri 63118, made application 
by renewal to the Drug Enforcement Administration (DEA) for 
registration as an importer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
Ethylamphetamine (1475)..........................  I
Aminorex (1585)..................................  I
Gamma Hydroxybutyric Acid (2010).................  I
Methaqualone (2565)..............................  I
Alpha-ethyltryptamine (7249).....................  I
Ibogaine (7260)..................................  I
Lysergic acid diethylamide (7315)................  I
Marihuana (7360).................................  I

[[Page 47107]]

 
Tetrahydrocannabinols (7370).....................  I
Mescaline (7381).................................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......  I
4-Methyl-2,5-dimethoxyamphetamine (7395).........  I
2,5-Dimethoxyamphetamine (7396)..................  I
3,4-Methylenedioxyamphetamine (7400).............  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)..  I
4-Methoxyamphetamine (7411)......................  I
Bufotenine (7433)................................  I
Diethyltryptamine (7434).........................  I
Dimethyltryptamine (7435)........................  I
Psilocybin (7437)................................  I
Psilocyn (7438)..................................  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).....  I
N-Benzylpiperazine (BZP) (7493)..................  I
Heroin (9200)....................................  I
Normorphine (9313)...............................  I
Etonitazene (9624)...............................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Methylphenidate (1724)...........................  II
Amobarbital (2125)...............................  II
Pentobarbital (2270).............................  II
Secobarbital (2315)..............................  II
Glutethimide (2550)..............................  II
Nabilone (7379)..................................  II
Phencyclidine (7471).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Diprenorphine (9058).............................  II
Oxycodone (9143).................................  II
Hydromorphone (9150).............................  II
Diphenoxylate (9170).............................  II
Ecgonine (9180)..................................  II
Ethylmorphine (9190).............................  II
Hydrocodone (9193)...............................  II
Levorphanol (9220)...............................  II
Meperidine (9230)................................  II
Methadone (9250).................................  II
Morphine (9300)..................................  II
Thebaine (9333)..................................  II
Opium, powdered (9639)...........................  II
Levo-alphacetylmethadol (9648)...................  II
Oxymorphone (9652)...............................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis.
    In reference to drug codes 7360 and 7370, the company plans to 
import a synthetic cannabidiol and a synthetic Tetrahydrocannabinol. No 
other activity for this drug code is authorized for this registration.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007).
    In regard to the non-narcotic raw material, any bulk manufacturer 
who is presently, or is applying to be, registered with DEA to 
manufacture such basic classes of controlled substances listed in 
schedules I or II, which fall under the authority of section 
1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the 
circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than September 6, 2012.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants 
for registration to import a basic classes of any controlled substance 
in schedules I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR Sec.  1301.34(b), (c), (d), (e), and (f) are satisfied.


[[Page 47108]]


    Dated: July 30, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-19191 Filed 8-6-12; 8:45 am]
BILLING CODE 4410-09-P